Skip to main content
SpringerLink
Log in

Meningiomas

  • Chapter
Tumor Neurosurgery

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

Abstract

The epidemiology, pathology, natural history, and recurrence of meningiomas are reviewed, as are treatment options and their indications. Several important surgical concepts are presented, with an emphasis on general principles that apply to resection of meningiomas at most intracranial locations. The role of therapeutic radiation — including gamma-knife radiosurgery, linear accelerator radiosurgery and intensity-modulated radiation therapy — is discussed. A review of current understanding of meningioma tumor biology is presented, as is the possible direction of future therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rachlin JR, Rosenblum ML. Etiology and biology of meningiomas. In: Al-Mefty O, editor. Meningiomas. New York: Raven Press, 1991; 27–35.

    Google Scholar 

  2. DeMonte F, Al Mefty O. Meningiomas. In: Kaye AH, Laws ER Jr, editors. Brain Tumors. New York: Churchill Livingstone, 1995; 675–704.

    Google Scholar 

  3. Kurland LT, Schoenberg BS, Annegers JF et al. The incidence of primary intracranial neoplasms in Rochester, Minnesota. Ann N Y Acad Sci 1982;381:6–16.

    Article  CAS  PubMed  Google Scholar 

  4. Nakasu S, Hirano A, Shimura T et al. Incidental meningiomas in autopsy study. Surg Neurol 1987;27:319–22.

    Article  CAS  PubMed  Google Scholar 

  5. Fan KJ, Pezeshkpour GH. Ethnic distribution of primary central nervous system tumors in Washington DC, 1971–1985. J Natl Med Assoc 1992;84:858–63.

    CAS  PubMed  Google Scholar 

  6. Haddad G, AL-Mefty O. Meningiomas: an overview. In Wilkins RH, Rengachary SS, editors. Neurosurgery. New York: McGraw-Hill, 1996; 833–41.

    Google Scholar 

  7. Drake JM, Hoffman HJ. Meningiomas in children. In Al-Mefty O, editor. Meningiomas. New York: Raven Press, 1991; 145–52.

    Google Scholar 

  8. Ersahin A, Ozdamar N, Demirtas E, Karabiyikoglu M. Meningioma of the cavernous sinus in a child. Childs Nerv Syst 1999;15(1):8–10.

    Article  CAS  PubMed  Google Scholar 

  9. Giangaspero F, Guiducci A, Lenz FA, Mastronardi L, Burger PC. Meningioma with meningoangiomatosis: a condition mimicking invasive meningiomas in children and young adults: report of two cases and review of the literature. Am J Surg Pathol 1999;23:872–5.

    Article  CAS  PubMed  Google Scholar 

  10. Inskip PD, Mellelkjaer L, Gridley G, Olsen JH. Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control 1998;9(1):109–16.

    Article  Google Scholar 

  11. Parent AD. Multiple meningiomas. In: Al-Mefty O, editor. Meningiomas. New York: Raven Press, 1991;161–8.

    Google Scholar 

  12. Levy WJ Jr, Bay J, Dohn D. Spinal cord meningiomas. J Neurosurg 1982;57:804–12.

    Article  PubMed  Google Scholar 

  13. Fox J. Meningiomas and associated lesions. In: Al-Mefty O, editor. Meningiomas. New York: Raven Press, 1991;129–36.

    Google Scholar 

  14. Iida A, Kurose K, Isobe R, Akiyama F, Sakamoto G, Yoshimoto M et al. Mapping of a new target region of allelic loss to a 2-cM interval at 22ql3.1 in primary breast cancer. Genes Chromosomes Cancer 1998;21(2):108–12.

    Article  Google Scholar 

  15. Kuratsu JI, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000;92:766–70.

    Article  CAS  PubMed  Google Scholar 

  16. Jaaskelainen J, Haltia M, Laasonen E, Wahlstrom T, Valtonen S. The growth rate of intracranial meningiomas in its relation to histology. An analysis of 43 patients. Surg Neurol 1985;24:165–72.

    Article  CAS  PubMed  Google Scholar 

  17. Cho K, Hoshiro T, Nagashima T, Murovic J, Wilson C. Predication of tumor doubling time in recurrent meningiomas. J Neurosurg 1986;65:790–4.

    Article  CAS  PubMed  Google Scholar 

  18. Shino A, Nakasu S, Matsuda M, Handa J, Morikawa S, Inubushi T. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 1999;91:928–34.

    Article  CAS  PubMed  Google Scholar 

  19. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. Neurol Nerosurg Psychiat 1957;20:22–39.

    Article  CAS  Google Scholar 

  20. Melamed S, Sahar A, Beller AJ. The recurrence of intracranial meningiomas. Neurochirurgie 1979;22:47–51.

    CAS  Google Scholar 

  21. Chan R, Thompson G. Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 1984;60:52–60.

    Article  CAS  PubMed  Google Scholar 

  22. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985;62:18–24.

    Article  CAS  PubMed  Google Scholar 

  23. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningiomas. Neurosurgery 1992;31:2–12.

    Article  CAS  PubMed  Google Scholar 

  24. Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic menigiomas: radiology surgery, radiotherapy, and outcome. Surg Neurol 1986;25:233–42.

    Article  CAS  PubMed  Google Scholar 

  25. Kakinuma K, Tanaka R, Onda K, Takahashi H. Proliferative potential of recurrent intracranial meningiomas as evaluated by labeling indices of BUdR and KI-67, and tumor doubling time. Acta Neurochir (Wien) 1998;140:26–31.

    Article  CAS  Google Scholar 

  26. May P, Broome J, Lawry J, Buxton R, Battersby R. A flow cytometric study of paraffin-embedded archival material. J Neurosurg 1989;71:347–51.

    Article  CAS  PubMed  Google Scholar 

  27. Mantle R, Lach B, Delgado M, Baeesa S, Belanger G. Predicting the probability of meningioma recurrence based on the quality of peritumoral brain edema on computerized tomography scanning. J Neurosurg 1999;91:375–83.

    Article  CAS  PubMed  Google Scholar 

  28. Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J. Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 1999;90:455–62.

    Article  CAS  PubMed  Google Scholar 

  29. Lee JH, Evans JJ, Kosmorsky G. Surgical management of clinoidal meningiomas. Neurosurgery 2001;48:1012–21.

    Article  CAS  PubMed  Google Scholar 

  30. Nutting C, Brada M, Brazil L et al. Radiotherapy in the treatment of benign meningiomas of the skull base. J Neurosurg 1999;90:823–7.

    Article  CAS  PubMed  Google Scholar 

  31. Patil AA, Kumar P, Leibrock LG. Response to extraaxial tumors to stereotactically implanted high-activity 1–125 seeds. Stereotactic Funct Neurosurg 1995;64:139–52.

    CAS  Google Scholar 

  32. Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD. Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg 1999;91:44–50.

    Article  CAS  PubMed  Google Scholar 

  33. Morita A, Coffey RJ, Foote RL, Schiff D, Gorman D. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg 1999;90:42–9.

    Article  CAS  PubMed  Google Scholar 

  34. Shafron DH, Friedman WA, Buatti JM, Bova FJ, Mendenhall WM. Linac radiosurgery for benign meningiomas. Int J Radiat Oncol Biol Phys 1999;43:321–7.

    CAS  PubMed  Google Scholar 

  35. Hakim R, Alexander E 3rd, Loeffler JS et al. Results of linear accelerator-basedradiosurgery for intracranial meningiomas. Neurosurgery 1998;42:446–53.

    Article  CAS  PubMed  Google Scholar 

  36. Kondziolka D, Flickinger JC, Perez B. Judicious resection and/or radiosurgery for parasagittal meningiomas: outcomes from a multicenter review. Gamma Knife Meningioma Study Group. Neurosurgery 1998;43:405–13.

    Article  CAS  PubMed  Google Scholar 

  37. Shen J-L, Loeb LA. The Werner syndrome gene: the molecular basis of RecQ helicase-deficiency diseases. Trends Genet 2000;16:213–20.

    Article  CAS  PubMed  Google Scholar 

  38. Huynh DP, Pulst SM. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene 1996;13:73–84.

    CAS  PubMed  Google Scholar 

  39. Goutebroze L, Brault E, Muchardt C, Camonis J, Thomas G. Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins. Mol Cell Biol 2000;20:1699–1712.

    Article  CAS  PubMed  Google Scholar 

  40. Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 2000;9:1495–1500.

    Article  CAS  PubMed  Google Scholar 

  41. Kirsch M, Zhu JJ, Black PM. Analysis of the BRCA1 and BRCA2 genes in sporadic meningiomas. Genes Chromosomes Cancer 1997;20:53–9.

    Article  CAS  PubMed  Google Scholar 

  42. Cho H, Ha SY, Park SH, Park K, Chae YS. Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas. J Korean Med Sci 1999;14:199–205.

    CAS  PubMed  Google Scholar 

  43. Santarius T, Kirsch M, Nikas DC, Imitoal J, Black PM. Molecular analysis of alteration of the pl8INK4c gene in human meningiomas. Neuropathol Appl Neurobiol 2000;26:67–75.

    Article  CAS  PubMed  Google Scholar 

  44. Mueller P, Henn W, Niedermayer I, Ketter R, Feiden W, Steudel WI et al. Deletion of chromosome lp and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 1999;5:3569–77.

    Google Scholar 

  45. Scoles DR, Huynh DP, Chen MS, Burke SP, Gutmann DH, Pulst S-M. The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth-factor regulated tyrosine kinase substrate. Hum Mol Genet 2000;9:1567–74.

    Article  CAS  PubMed  Google Scholar 

  46. Cooper C, Jones HG, Weller RO et al. Production of prostaglandins and thromoboxane by isolated cells from intracranial tumors. J Neurol Neurosurg Psychiatry 1984;47:579–84.

    Article  CAS  PubMed  Google Scholar 

  47. Scanlon KJ, Kashani-Sabet M. Ribozymes as therapeutic agents: are we getting closer? J Natl Cancer Inst 1998;90:558–9.

    Article  CAS  PubMed  Google Scholar 

  48. Levitzki A. Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacol Ther 1999;82:231–9.

    Article  CAS  PubMed  Google Scholar 

  49. Sebolt-Leopold JS, Dudley DT, Herrera R et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 1999;5:810–16.

    Article  CAS  PubMed  Google Scholar 

  50. Smigel K. Arthritis drug approved for polyp prevention blazes trail for other prevention trials. J Natl Cancer Inst 2000;92:297–9.

    Article  CAS  PubMed  Google Scholar 

  51. Park YS, Lee JH, Harwalkar JA, Bondar J, Safayhi H, Golubic M. Acetyl-HB-Boswellic Acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2. In: Honn KV, Nigam S, Marnett IJ, Dennis E, editors. Proceedings of the 6th International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases. New York: Plenum Publishing, 2000.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neuro-oncologic Neurosurgery and Stereotactic Radiosurgery Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA

    James J. Evans MD

  2. Section of Skull Base Surgery Brain Tumor Institute/Department of Neurosurgery, The Cleveland Clinic Foundation, Cleveland, OH, USA

    Joung H. Lee MD

  3. Department of Radiation Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA

    John Suh MD

  4. Brain Tumor Institute/Department of Neurosurgery, The Cleveland Clinic Foundation, Cleveland, OH, USA

    Mladen Golubic MD, PhD

Authors
  1. James J. Evans MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joung H. Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Suh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mladen Golubic MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. South West Neurosurgery Centre, Derriford Hospital, Plymouth, UK

    Anne J. Moore MB BS, BSc, FRCS

  2. The Seattle Neuroscience Institute, Seattle, WA, USA

    David W. Newell

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Evans, J.J., Lee, J.H., Suh, J., Golubic, M. (2006). Meningiomas. In: Moore, A.J., Newell, D.W. (eds) Tumor Neurosurgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/978-1-84628-294-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-294-2_12

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-291-1

  • Online ISBN: 978-1-84628-294-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation